Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 206
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotic Resistance: Between the Environment and Our Bodies

Bacteria have evolved many genes to make them resistant to most of our antibiotics. Such genes can be moved...

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

The Effects of Sudarshan Kriya Yoga (SKY) in patients with Post Traumatic Stress Disorder (PTSD)

Sudarshan Kriya Yoga (SKY) is a standardized series of breathing techniques that has beneficial effects on the...

Backer Badge Funded